DEFA14A: Akoustis Technologies Granted Continued Nasdaq Listing Subject to Compliance

Akoustis Technologies receives conditional approval for continued listing on The Nasdaq Capital Market, contingent on meeting minimum bid price and stockholders' equity requirements.

Summary

• Akoustis Technologies received a notice from Nasdaq regarding its non-compliance with the minimum bid price and stockholders' equity requirements.
• The company appealed the delisting determination and presented its compliance plans to the Nasdaq Hearings Panel.
• On October 14, 2024, the Panel granted Akoustis continued listing, subject to demonstrating compliance with the minimum bid price by December 17, 2024.
• Akoustis must also provide an update on its efforts to regain compliance with the stockholders' equity requirement by January 31, 2025.
• The company is considering a reverse stock split, to be voted on at the annual meeting on November 21, 2024, to address the minimum bid price requirement.
• There is no assurance that Akoustis will regain compliance with either requirement.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the company's non-compliance with Nasdaq listing requirements and the risk of delisting. However, the conditional approval for continued listing provides some hope for improvement.

Positives

• Akoustis Technologies has been granted continued listing on The Nasdaq Capital Market, avoiding immediate delisting.
• The company has a plan to address the minimum bid price requirement through a potential reverse stock split.
• The Nasdaq Hearings Panel has provided a timeline for Akoustis to regain compliance with listing requirements.

Negatives

• Akoustis Technologies is currently not in compliance with Nasdaq's minimum bid price and stockholders' equity requirements.
• There is no guarantee that the company will regain compliance with these requirements within the given timeframe.
• Delisting from Nasdaq would have a material and adverse effect on the company's ability to raise capital and its financial condition.

Risks

• The company may not obtain stockholder approval for the reverse stock split.
• Akoustis may fail to cure its deficiency in compliance with the minimum bid price requirement by December 17, 2024.
• The company may not be able to present a satisfactory update regarding its efforts to regain compliance with the stockholders' equity requirement by January 31, 2025.
• Akoustis may fail to maintain compliance with other Nasdaq Listing Rules during the compliance period.
• The company faces risks related to the substantial costs and diversion of personnel's attention and resources due to these matters.

Future Outlook

The company must regain compliance with Nasdaq's minimum bid price and stockholders' equity requirements to maintain its listing. Failure to do so could result in delisting, which would negatively impact its ability to raise capital and its financial condition.

Industry Context

Many small-cap companies face challenges in maintaining Nasdaq listing compliance, especially during periods of financial difficulty or market volatility. Reverse stock splits are a common strategy to increase the share price and meet minimum bid requirements.

Comparison to Industry Standards

• Other companies facing similar Nasdaq compliance issues include those in the biotechnology and technology sectors, which often experience volatile stock prices.
• Reverse stock splits are a frequently used method, but their success depends on the company's ability to improve its underlying financial performance and investor confidence.
• Companies like [Comparable Company A] and [Comparable Company B] have previously used reverse stock splits to regain compliance, with varying degrees of success.

Stakeholder Impact

• Shareholders face the risk of further stock dilution if the reverse stock split is implemented and the company's financial performance does not improve.
• Employees may experience uncertainty due to the company's financial challenges and the potential for delisting.
• The company's ability to secure contracts and partnerships may be affected by its Nasdaq listing status.

Next Steps

• Akoustis Technologies will seek stockholder approval for a reverse stock split at the Annual Meeting on November 21, 2024.
• The company must demonstrate compliance with the Minimum Bid Price Requirement by December 17, 2024.
• Akoustis Technologies must provide an update regarding its efforts to regain compliance with the Stockholders Equity Requirement by January 31, 2025.

Key Dates

Keywords

Nasdaq, Delisting, Compliance, Minimum Bid Price, Stockholders Equity, Reverse Stock Split, Listing Rule, Akoustis Technologies